The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
about
Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature reviewLevels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study.Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis.The association of immunoglobulin A, immunoglobulin G and anti-cyclic citrullinated peptide antibodies with disease activity in seronegative rheumatoid arthritis patientsA systematic review of serum biomarkers anti-cyclic citrullinated Peptide and rheumatoid factor as tests for rheumatoid arthritisInsights to clinical use of serial determination in titers of cyclic citrullinated peptide autoantibodies.Clinical and magnetic resonance imaging findings of the temporomandibular joint in patients with rheumatoid arthritis.The Clinical Application of Anti-CCP in Rheumatoid Arthritis and Other Rheumatic Diseases.Dentofacial characteristics of patients with rheumatoid arthritis.Effect of conjugated linoleic Acid, vitamin e, alone or combined on immunity and inflammatory parameters in adults with active rheumatoid arthritis: a randomized controlled trial.Age-related diagnostic utility of rheumatoid factor, anticyclic citrullinated peptide and antikeratin antibodies in Chinese patients with rheumatoid arthritis.Pre-treatment interleukin-6 levels strongly affect bone erosion progression and repair detected by magnetic resonance imaging in rheumatoid arthritis patients.Anti-arthritic effect of GN1, a novel synthetic analog of glucosamine, in the collagen-induced arthritis model in rats.Baseline serum level of matrix metalloproteinase-3 as a biomarker of progressive joint damage in rheumatoid arthritis patients.Cartilage Oligomeric Matrix Protein Level in Rheumatic Diseases: Potential Use as a Marker for Measuring Articular Cartilage Damage and/or the Therapeutic Efficacy of Treatments
P2860
Q24675281-756E1498-6CFE-4C05-93AB-3ECB079F0A4AQ33873636-E5604403-DCF8-448E-864B-A523EBC4D2C7Q34367709-312A60F9-0214-47F6-ACF5-A23FE79AB302Q34715920-30B1C32B-3DE9-43E6-B047-E90B4E5937CCQ35207886-1D79D62B-7A9E-43B9-9818-14B77ACB89A1Q35741161-0EA50D0E-D559-4985-9619-43CE6A038968Q36254534-3244C482-56BC-46D5-8EB4-E9C08B765D19Q37280952-918E030B-9773-4AC3-A906-F444FD30E9F3Q39538922-7B9676A1-7FF4-4499-83A5-FB5E264F91C8Q43158230-128BED45-ABB7-4D57-8753-6F18B914D575Q43633174-69087B0F-7DEE-4E34-8C9A-C44BB2C6268EQ51087844-4856CED4-77F2-44FD-82FF-55D00BA74371Q51421445-CE369837-C100-4869-B11D-05F4036F8AA2Q53826993-30F71E66-9DB6-42B7-876B-71E9B17671DDQ56802112-AE068F47-753E-4ED8-8982-21F56460988A
P2860
The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The diagnostic utility of anti ...... -erosive rheumatoid arthritis.
@ast
The diagnostic utility of anti ...... -erosive rheumatoid arthritis.
@en
type
label
The diagnostic utility of anti ...... -erosive rheumatoid arthritis.
@ast
The diagnostic utility of anti ...... -erosive rheumatoid arthritis.
@en
prefLabel
The diagnostic utility of anti ...... -erosive rheumatoid arthritis.
@ast
The diagnostic utility of anti ...... -erosive rheumatoid arthritis.
@en
P50
P1476
The diagnostic utility of anti ...... -erosive rheumatoid arthritis.
@en
P2093
P304
P356
10.1080/17402520500233510
P577
2005-09-01T00:00:00Z